AzTrials
AzTrials

Social AnxietyNCT03547713

A Neuropsychological Characterization of Social Feedback Processing in Social Anxiety

A study testing Social feedback, Self-referential paradigm and Reward vs. punishment task in people with Social Anxiety, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to characterize neuropsychological mechanisms (positive affect, negative affect and self-evaluation) mediating processing of social feedback in people with different levels of social anxiety, by implementing functional and structural MRI. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Social Anxiety
What is being tested?
Social feedback, Self-referential paradigm and Reward vs. punishment task
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteIsrael
Study dates
2 Mar 2018to 23 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy participants
  • With different levels of social anxiety as measured by the Liebowitz Social Anxiety Scale-Self-Report (LSAS-SR; Fresco et al., 2001)
  • Normal or corrected-to-normal vision
  • Compatibility with general MRI requirements

Who cannot join

  • History of neurological or psychiatric diseases

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Tel-Aviv Sourasky medical center

    Tel Aviv, 6423906

Other trials in Israel

About this study

The purpose of this study is to characterize neuropsychological mechanisms (positive affect, negative affect and self-evaluation) mediating processing of social feedback in people with different levels of social anxiety, by implementing functional and structural MRI.

Read the detailed description

Social anxiety (SA) disorder is a relatively widespread emotional disorder which is associated with considerable impairment in social, educational, and occupational functioning (Kessler et al., 2005). This condition is characterized by a debilitating preoccupation with the evaluation of the self by others, ultimately leading to excessive fear and avoidance of interpersonal encounters. As opposed to healthy individuals who typically process social feedback in a positively biased manner, Individuals with high levels of SA tend to evaluate the feedback conveyed by others negatively. Such biases have a profound contribution to the maintenance of social-related concerns (Clark \& Wells, 1995).

Thus, the overreaching goal of this research is to provide a neuropsychological account of biased processing of social feedback evident in SA. To meet this goal, participants varying in their level of SA are asked to deliver a speech and evaluate it before and after receiving social feedback during an fMRI scan. Additional structural and resting-state fMRI scans, as well as physiological and psychological measures, are obtained throughout the experiment in order to explain individual differences in processing of feedback. fMRI tasks probing basic neuropsychological processes include a self-referential paradigm, wherein participants judge if different traits varying in valence and social domain (power vs. affiliation) are descriptive of them; a reward vs. punishment task, in which participants can win or lose money; and an emotional reactivity task, in which participants view faces with different emotional expressions.

The long-term goal of this study is to better delineate both neurobiological and psychological models of SA, as well as to help in directing future neuromodulation-based treatments of mood and anxiety disorders.

Conditions
Social Anxiety
Being tested
Social feedback, Self-referential paradigm, Reward vs. punishment task, Emotional reactivity task

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Social feedbackBehavioural

    Social feedback regarding performance of a public speech is delivered to participants

  • Self-referential paradigmBehavioural

    Exposure to traits varying in valence (positive vs. negative) and social domain (power vs. affiliation)

  • Reward vs. punishment taskBehavioural

    Reception of monetary gains vs. losses

  • Emotional reactivity taskBehavioural

    Exposure to emotional faces vs. shapes

Study groups in NCT03547713
Study groupRoleWhat they receive
Study groupExperimentalsocial feedback and neuropsychological assessment
Receives: Behavioral: Social feedback; Behavioral: Self-referential paradigm; Behavioral: Reward vs. punishment task; Behavioral: Emotional reactivity task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in evaluation of a public performance

    Rating of a public performance made on a 0-10 scale before vs. after reception of social feedback

    Measured: 1 day

  2. Correlation of social feedback processing with neural indices and anxiety levels

    1. Neural activation and functional connectivity measured during processing of social feedback with different values.
    2. Neural activation and functional connectivity measured in fMRI tasks probing elemental neuropsychological processes:

    2.A. Processing of self-descriptive traits differing in valence (positive vs. negative) and social domain (power vs. affiliation).

    2.B. Response to emotional faces. 2.C. Anticipating and receiving monetary reward vs. loss. 3. Brain functional connectivity obtained during resting-state scans obtained at three time-points: a) before the speech; b) before feedback reception; c) after feedback reception.

    1. We will assess the correlation between multiple measurements (i.e. anxiety levels, behavioral indices of speech evaluation bias, and the battery of fMRI tasks) by implementing multivariate and multiparametric statistical models.

    Measured: 1 day

Secondary outcomes (1)
  1. Correlation of self-representation processes with neural indices and anxiety levels

    1. Neural activation and functional connectivity measured during processing of social feedback with different values.
    2. Neural activation and functional connectivity measured in fMRI tasks probing elemental neuropsychological processes: b1. Processing of self-descriptive traits differing in valence (positive vs. negative) and social domain (power vs. affiliation). b2. Response to emotional faces. b3. Anticipating and receiving monetary reward vs. loss.
    3. Brain functional connectivity obtained during resting-state scans obtained at three time-points: before the speech, before feedback reception and after feedback reception.
    4. We will assess the correlation between multiple measurements (i.e. anxiety levels, behavioral indices of speech evaluation bias, and the battery of fMRI tasks) by implementing multivariate and multiparametric statistical models.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2018
  2. Study start2 Mar 2018
  3. Primary completion23 Oct 2018
  4. Study completion23 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
58 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03547713
Sponsor's protocol ID
TASMC-18-TH-0082-17-TLV-CTIL
Status last verified
May 2018
First submitted
14 May 2018
Last updated
11 Mar 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, Goetz D. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med. 2001 Aug;31(6):1025-35. doi: 10.1017/s0033291701004056.

    PubMed 11513370
  • Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.

    PubMed 15939839
  • Clark, D. M., & Wells, A. (1995). A cognitive model of social phobia. Social Phobia: Diagnosis, Assessment, and Treatment, 41(68), 00022-3.

Questions about this trial

What is this clinical trial studying?

A study testing Social feedback, Self-referential paradigm and Reward vs. punishment task in people with Social Anxiety, run by Tel-Aviv Sourasky Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in evaluation of a public performance (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03547713, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in